Successful treatment of central nervous system involvement in posttransplant EBV-related lymphoproliferative disease with intrathecal rituximab therapy

Aslan, FatmaGüler, SalihEvim, Melike SezginAslıer, MustafaYazıcı, ZeynepNazlıoğlu, Hülya ÖztürkGüneş, Adalet Meral2024-11-122024-11-122023-07-011077-4114https://doi.org/10.1097/MPH.0000000000002592https://journals.lww.com/jpho-online/fulltext/2023/07000/successful_treatment_of_central_nervous_system.26.aspxhttps://hdl.handle.net/11452/47744The posttransplant lymphoproliferative disease is a severe cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. Central Nervous System involvement in EBV-related PTLD is rare, and there is no standard treatment recommendation. We present our patient and discuss other previously reported cases of EBV-associated PTLD with CNS involvement.eninfo:eu-repo/semantics/closedAccessStem-cell transplantationCnsCns involvementPtldHsctIntrathecal rituximabOncologyHematologyPediatricsSuccessful treatment of central nervous system involvement in posttransplant EBV-related lymphoproliferative disease with intrathecal rituximab therapyArticle001017782300026E628E63045510.1097/MPH.0000000000002592